Selpercatinib + Cyp3a Inducers Interaction
Moderateinteraction on record
Description
Concomitant use decreases selpercatinib plasma concentrations, which may reduce anti-tumor activity. Avoid coadministration.
Mechanism
CYP3A induction decreases selpercatinib plasma concentrations
Source: NLP:selpercatinib